Literature DB >> 25139107

Montreal Cognitive Assessment (MoCA)-Italian version: regression based norms and equivalent scores.

Silvia Conti1, Stefano Bonazzi, Marcella Laiacona, Marco Masina, Mirco Vanelli Coralli.   

Abstract

The Montreal Cognitive Assessment (MoCA) is a brief cognitive screening instrument developed by Nasreddine et al. to detect mild cognitive impairment, a high-risk condition for Alzheimer's disease and other forms of dementia. In this study we report normative data on the MoCA-Italian version, collected on a sample of 225 Italian healthy subjects ranged in age between 60 and 80 years, and in formal education from 5 to 23 years. The global normal cognition was established in accordance with the Mini-Mental State Examination score and with the Prose Memory Test score (Spinnler and Tognoni, Ital J Neurol Sci 6:25-27, 1987). None of the participants had a history of psychiatric, neurological, cerebrovascular disorders or brain injury or took drugs affecting cognition. Linear regression analysis was performed to evaluate the potential effect of age, education and sex on the MoCA total performance score. We provide correction grids to adjust raw scores and equivalent scores with cut-off value to allow comparison between MoCA performance and others neuropsychological test scores that can be administered on the same subject.

Entities:  

Mesh:

Year:  2014        PMID: 25139107     DOI: 10.1007/s10072-014-1921-3

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  16 in total

1.  Montreal Cognitive Assessment (MoCA): normative study for the Portuguese population.

Authors:  Sandra Freitas; Mário R Simões; Lara Alves; Isabel Santana
Journal:  J Clin Exp Neuropsychol       Date:  2011-07-04       Impact factor: 2.475

2.  Comparison between the story recall test and the word-list learning test in Korean patients with mild cognitive impairment and early stage of Alzheimer's disease.

Authors:  Min Jae Baek; Hyun Jung Kim; Sangyun Kim
Journal:  J Clin Exp Neuropsychol       Date:  2012-01-23       Impact factor: 2.475

3.  Normative data for the Montreal Cognitive Assessment (MoCA) in a population-based sample.

Authors:  Ziad S Nasreddine; Natalie Phillips; Howard Chertkow
Journal:  Neurology       Date:  2012-03-06       Impact factor: 9.910

4.  The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment.

Authors:  Ziad S Nasreddine; Natalie A Phillips; Valérie Bédirian; Simon Charbonneau; Victor Whitehead; Isabelle Collin; Jeffrey L Cummings; Howard Chertkow
Journal:  J Am Geriatr Soc       Date:  2005-04       Impact factor: 5.562

5.  The Frontal Assessment Battery (FAB): normative values in an Italian population sample.

Authors:  I Appollonio; M Leone; V Isella; F Piamarta; T Consoli; M L Villa; E Forapani; A Russo; P Nichelli
Journal:  Neurol Sci       Date:  2005-06       Impact factor: 3.307

Review 6.  Current concepts in mild cognitive impairment.

Authors:  R C Petersen; R Doody; A Kurz; R C Mohs; J C Morris; P V Rabins; K Ritchie; M Rossor; L Thal; B Winblad
Journal:  Arch Neurol       Date:  2001-12

7.  Absence of a relationship between subjective memory complaint and objective memory impairment in mild cognitive impairment (MCI): is it time to abandon subjective memory complaint as an MCI diagnostic criterion?

Authors:  Megan Elizabeth Lenehan; Shannon Zofia Klekociuk; Mathew James Summers
Journal:  Int Psychogeriatr       Date:  2012-05-01       Impact factor: 3.878

8.  Comparison of verbal memory impairment rates in mild cognitive impairment.

Authors:  Geoffrey Tremont; Andrea Miele; Megan M Smith; Holly James Westervelt
Journal:  J Clin Exp Neuropsychol       Date:  2010-07       Impact factor: 2.475

9.  Normative data for the montreal cognitive assessment in a Japanese community-dwelling older population.

Authors:  Kenji Narazaki; Yu Nofuji; Takanori Honda; Eri Matsuo; Koji Yonemoto; Shuzo Kumagai
Journal:  Neuroepidemiology       Date:  2012-10-11       Impact factor: 3.282

10.  Memory complaint is not necessary for diagnosis of mild cognitive impairment and does not predict 10-year trajectories of functional disability, word recall, or short portable mental status questionnaire limitations.

Authors:  Jama L Purser; Gerda G Fillenbaum; Robert B Wallace
Journal:  J Am Geriatr Soc       Date:  2006-02       Impact factor: 5.562

View more
  60 in total

1.  Sex-related differences in olfactory function and evaluation of possible confounding factors among patients with Parkinson's disease.

Authors:  P Solla; C Masala; A Liscia; R Piras; T Ercoli; L Fadda; T Hummel; A Haenher; G Defazio
Journal:  J Neurol       Date:  2019-09-25       Impact factor: 4.849

2.  Correlation among olfactory function, motors' symptoms, cognitive impairment, apathy, and fatigue in patients with Parkinson's disease.

Authors:  Carla Masala; Paolo Solla; A Liscia; G Defazio; L Saba; A Cannas; A Cavazzana; T Hummel; A Haehner
Journal:  J Neurol       Date:  2018-05-26       Impact factor: 4.849

3.  Comparison of alternate and original forms of the Montreal Cognitive Assessment (MoCA): an Italian normative study.

Authors:  Mattia Siciliano; Carlo Chiorri; Carla Passaniti; Valeria Sant'Elia; Luigi Trojano; Gabriella Santangelo
Journal:  Neurol Sci       Date:  2019-01-14       Impact factor: 3.307

4.  Apathy in corticobasal degeneration: possible parietal involvement.

Authors:  Rita Moretti; R Caberlotto; R Signori
Journal:  Funct Neurol       Date:  2017 Oct/Dec

Review 5.  Translations and cultural adaptations of the Montreal Cognitive Assessment: a systematic and qualitative review.

Authors:  Ilaria Cova; Alessia Nicotra; Giorgia Maestri; Marco Canevelli; Leonardo Pantoni; Simone Pomati
Journal:  Neurol Sci       Date:  2021-11-09       Impact factor: 3.307

6.  Normative Data for the Montreal Cognitive Assessment in Middle-Aged and Elderly Quebec-French People.

Authors:  Eddy Larouche; Marie-Pier Tremblay; Olivier Potvin; Sophie Laforest; David Bergeron; Robert Laforce; Laura Monetta; Linda Boucher; Pascale Tremblay; Sylvie Belleville; Dominique Lorrain; Jean-François Gagnon; Nadia Gosselin; Christian-Alexandre Castellano; Stephen C Cunnane; Joël Macoir; Carol Hudon
Journal:  Arch Clin Neuropsychol       Date:  2016-11-22       Impact factor: 2.813

7.  A double-blind randomized controlled trial of the efficacy of cognitive training delivered using two different methods in mild cognitive impairment in Parkinson's disease: preliminary report of benefits associated with the use of a computerized tool.

Authors:  Sara Bernini; Silvia Panzarasa; Marica Barbieri; Elena Sinforiani; Silvana Quaglini; Cristina Tassorelli; Sara Bottiroli
Journal:  Aging Clin Exp Res       Date:  2020-09-08       Impact factor: 3.636

8.  Evaluation of the efficacy of physical therapy on cognitive decline at 6-month follow-up in Parkinson disease patients with mild cognitive impairment: a randomized controlled trial.

Authors:  Micol Avenali; Marta Picascia; Cristina Tassorelli; Elena Sinforiani; Sara Bernini
Journal:  Aging Clin Exp Res       Date:  2021-05-12       Impact factor: 3.636

9.  Lockdown Effects on Healthy Cognitive Aging During the COVID-19 Pandemic: A Longitudinal Study.

Authors:  Martina Amanzio; Nicola Canessa; Massimo Bartoli; Giuseppina Elena Cipriani; Sara Palermo; Stefano F Cappa
Journal:  Front Psychol       Date:  2021-05-24

10.  Identification of sixteen novel candidate genes for late onset Parkinson's disease.

Authors:  Alessandro Gialluisi; Mafalda Giovanna Reccia; Nicola Modugno; Teresa Nutile; Alessia Lombardi; Luca Giovanni Di Giovannantonio; Sara Pietracupa; Daniela Ruggiero; Simona Scala; Stefano Gambardella; Licia Iacoviello; Fernando Gianfrancesco; Dario Acampora; Maurizio D'Esposito; Antonio Simeone; Marina Ciullo; Teresa Esposito
Journal:  Mol Neurodegener       Date:  2021-06-21       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.